Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD

AstraZeneca2,717 enrolled

Overview

To describe the frequency, type and severity of the symptoms in patients visiting the GI or internal physicians, with symptoms consistent with gastroesophageal reflux disease (GERD)

Study Type

OBSERVATIONAL

Enrollment

2,717

Conditions

GERD

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients from both sexes, aged 18 years or older * Patients complaining of symptoms consistent with reflux disease Exclusion Criteria: * Patients with GI cancer and those where the only reason for the visit is renewing the prescription are excluded

Locations (2)

Research Site

Hanoi, Vietnam

Research Site

Ho Chi Minh City, Vietnam

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.